Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma

The addition of clarithromycin enhances the efficacy of lenalidomide plus dexamethasone in treatment-naive multiple myeloma (MM). We conducted a phase 2 trial to evaluate the safety and efficacy of clarithromycin, pomalidomide, and dexamethasone (ClaPd) in relapsed or refractory multiple myeloma (RR...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Blood Adv
Huvudupphovsmän: Mark, Tomer M., Forsberg, Peter A., Rossi, Adriana C., Pearse, Roger N., Pekle, Karen A., Perry, Arthur, Boyer, Angelique, Tegnestam, Linda, Jayabalan, David, Coleman, Morton, Niesvizky, Ruben
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Hematology 2019
Ämnen:
Clinical Trials and Observations
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6391672/
https://ncbi.nlm.nih.gov/pubmed/30792190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018028027
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk